CSI:OPIOIDs (Clinical Context of Suicide Following Opioid Transitions) is a scientific research study to closely examine suicides that have occurred after prescription opioid dose reductions in patients with long-term pain.
The CSI:OPIOIDs team will:
- Compile a registry of people who have died by suicide following a reduction or stoppage in their opioid medication.
- Perform in-depth, one on one interviews with survivors of individuals who have died by suicide after opioid transition to understand what led their loved-one to die by suicide, and review medical records when they are obtainable.
- Identify factors common to these individuals prior to their death and suggest ways to reduce likelihood that future patients will die by suicide under similar circumstances.
The approach used in this study, psychological autopsy, offers a descriptive portrait of each death. The resulting insights will help health systems, policy makers, and prescribers make better decisions to prevent these tragedies. There is a website for the general public and a separate one for persons who wish to enter the study
CSI:OPIOIDs (Clinical Context of Suicide Following Opioid Transitions) is a research study focused on closely examining suicides that have occurred after prescription opioid dose reductions in patients with long-term pain. Suicide is a complex event that is not fully explained by a change in prescription medication, and in-depth case study could help shed a deeper light on the social and clinical context of these tragedies so that they may be prevented. The study team has worked diligently to ensure that participant data is secure and protected and that
participants feel safe and heard throughout their interactions with this study. The study is approved by the Institutional Review Boards at both the University of Alabama at Birmingham and the US Department of Veterans Affairs; it is also covered by two National Institute of Health Certificates of Confidentiality to protect participant privacy and prohibit the disclosure of identifiable and sensitive information outside of the study.
To learn more about the study, please visit https://go.uab.edu/csi.
To talk to the study team and ask questions, please reach out to: [email protected].
For anyone thinking about suicide, please contact the 988 Suicide Crisis Lifeline, available
online, via chat, or by dialing “988.”